IL87646A - Preparation for the treatment of hepatitis virus containing 1 -) 2 '- Deoxy - 2' - Fluoro - Beta - B - D - Arabino - Furanozil (- 5 - Orcil - Google Patents

Preparation for the treatment of hepatitis virus containing 1 -) 2 '- Deoxy - 2' - Fluoro - Beta - B - D - Arabino - Furanozil (- 5 - Orcil

Info

Publication number
IL87646A
IL87646A IL8764688A IL8764688A IL87646A IL 87646 A IL87646 A IL 87646A IL 8764688 A IL8764688 A IL 8764688A IL 8764688 A IL8764688 A IL 8764688A IL 87646 A IL87646 A IL 87646A
Authority
IL
Israel
Prior art keywords
feau
day
fmau
virus
whv
Prior art date
Application number
IL8764688A
Other languages
English (en)
Hebrew (he)
Original Assignee
Sloan Kettering Inst Cancer
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Inst Cancer, Inst Nat Sante Rech Med filed Critical Sloan Kettering Inst Cancer
Publication of IL87646A publication Critical patent/IL87646A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL8764688A 1987-09-03 1988-09-01 Preparation for the treatment of hepatitis virus containing 1 -) 2 '- Deoxy - 2' - Fluoro - Beta - B - D - Arabino - Furanozil (- 5 - Orcil IL87646A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9244687A 1987-09-03 1987-09-03

Publications (1)

Publication Number Publication Date
IL87646A true IL87646A (en) 1994-07-31

Family

ID=22233256

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8764688A IL87646A (en) 1987-09-03 1988-09-01 Preparation for the treatment of hepatitis virus containing 1 -) 2 '- Deoxy - 2' - Fluoro - Beta - B - D - Arabino - Furanozil (- 5 - Orcil

Country Status (10)

Country Link
EP (1) EP0338042B1 (de)
JP (1) JPH02500524A (de)
KR (1) KR970011386B1 (de)
AU (1) AU2487688A (de)
CA (1) CA1328865C (de)
DE (1) DE3885090T2 (de)
ES (1) ES2014042A6 (de)
IL (1) IL87646A (de)
PT (1) PT88420B (de)
WO (1) WO1989001776A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
CN100349913C (zh) * 1998-02-25 2007-11-21 埃莫里大学 2′－氟代核苷
PT1411954E (pt) * 2000-10-18 2011-03-16 Pharmasset Inc Nucleosídeos modificados para o tratamento de infecções virais e proliferação celular anormal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211733A (en) * 1978-12-26 1980-07-08 Chang Shih Chih Gas-liquid mixing process and apparatus
US4666892A (en) * 1984-03-06 1987-05-19 Sloan-Kettering Memorial Cancer Center Method and composition for hepatitis treatment with pyrimidine nucleoside compounds
AU575918B2 (en) * 1984-03-06 1988-08-11 Sloan-Kettering Institute For Cancer Research Hepatitis treatment with pyrimidine nucleoside compounds

Also Published As

Publication number Publication date
ES2014042A6 (es) 1990-06-16
DE3885090D1 (de) 1993-11-25
EP0338042A4 (en) 1990-09-26
KR970011386B1 (ko) 1997-07-10
JPH02500524A (ja) 1990-02-22
CA1328865C (en) 1994-04-26
PT88420B (pt) 1993-12-31
PT88420A (pt) 1989-07-31
DE3885090T2 (de) 1994-05-11
EP0338042A1 (de) 1989-10-25
KR890701112A (ko) 1989-12-19
AU2487688A (en) 1989-03-31
WO1989001776A1 (en) 1989-03-09
EP0338042B1 (de) 1993-10-20

Similar Documents

Publication Publication Date Title
US5246924A (en) Method for treating hepatitis B virus infections using 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil
Öberg Antiviral effects of phosphonoformate (PFA, foscarnet sodium)
US7094770B2 (en) 3′-or 2′-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
CA1336820C (en) Fluorinated nucleosides and process for treating retrovirus infections therewith
White et al. A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates
EP0145739B1 (de) Neue antivirale agenzien
EP0277151B1 (de) Medizinische verwendung von nukleosiden
IE860677L (en) Antiviral formulation
Boezi The antiherpesvirus action of phosphonoacetate
Zoulim et al. 2', 3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo
WO1984004748A2 (en) Novel antiviral agents
WO2003080078A1 (en) Treatment of pre-core hepatitis b virus mutant infections
US5039667A (en) Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides
Schinazi et al. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2
EP0302760B1 (de) Antivirale Therapie gegen Hepatitis B mit 2',3'-Didesoxynucleosiden
EP0338042B1 (de) Zusammensetzung und verfahren zur behandlung von hepatitisvirusinfektionen unter verwendung von 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil
Prusoff et al. Physical and biological consequences of incorporation of antiviral agents into virus DNA
JP2001504468A (ja) Ｌ―β―ジオキソランウリジン類似体及びウイルス感染の治療とその予防方法
Nagahata et al. Effect of oxetanocin G, a novel nucleoside analog, on DNA synthesis by hepatitis B virus virions
Meisel et al. Inhibition of hepatitis B virus DNA polymerase by 3′‐fluorothymidine triphosphate and other modified nucleoside triphosphate analogs
EP0316592A2 (de) 3'-Fluor-2',3'-dideoxyuridin und seine therapeutische Verwendung
Stening et al. Antiherpes activity of [E]-5-(1-propenyl)-2′-deoxyuridine and 5-(1-propenyl)-1-β-d-arabinofuranosyluracil
Sim et al. Possible molecular basis for antiviral activity of certain 5-substituted deoxyuridines
HU198393B (en) Process for production of medical composition suitable for treatment of hepatitis containing as active substance derivatives of piramidin-nucleoside
EP1727814B1 (de) Nukleosidanaloga mit antiviraler wirkung

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired
EXP Patent expired